We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.13 | -0.29% | 44.46 | 44.72 | 44.46 | 44.49 | 3,474,852 | 21:46:26 |
From Nov 2023 to May 2024
By Christian Moess Laursen
GSK said it has bought Aiolos Bio, a biopharmaceutical company focused on patients with respiratory and inflammatory conditions, for an upfront consideration of $1.0 billion, with the potential for an additional $400 million.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
January 09, 2024 02:24 ET (07:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
